Quarterly report pursuant to Section 13 or 15(d)

Restricted Cash Equivalents and Investments (Tables)

v3.22.2.2
Restricted Cash Equivalents and Investments (Tables)
9 Months Ended
Sep. 30, 2022
Restricted Cash Equivalents and Investments [Abstract]  
Schedule of Cash Equivalents and Available-for-Sale Securities

September 30, 2022

Amortized Cost

Gross Unrealized
Gains

Gross Unrealized
Losses

Fair Value

Cash Equivalents

Short-Term
Investments

Long-Term
Investments

Cash equivalents:

Money Market Funds

$

959,541 

$

$

$

959,541 

$

959,541 

$

$

Subtotal

959,541 

959,541 

959,541 

Investments:

Corporate Notes/Bonds

2,725,561 

(71,178)

2,654,383 

2,654,383 

Subtotal

2,725,561 

(71,178)

2,654,383 

2,654,383 

Total

$

3,685,102 

$

$

(71,178)

$

3,613,924 

$

959,541 

$

2,654,383 

$

Schedule of Estimated Fair Value of Available-for-Sale Securities

Amortized Cost

Estimated Market
Value

Due within one year

$

2,725,561

$

2,654,383

Due after one year through five years

$

2,725,561

$

2,654,383